[Form 3] Vera Therapeutics, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Vera Therapeutics, Inc. (VERA)

11/26/2025 - 04:35 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meyers James R

(Last) (First) (Middle)

C/O VERA THERAPEUTICS, INC. 2000 SIERRA

POINT PARKWAY, SUITE 1200

(Street)

BRISBANE CA 94005

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/25/2025

3. Issuer Name and Ticker or Trading Symbol
Vera Therapeutics, Inc. [ VERA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Joseph Young, attorney-in-fact	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does this Form 3 filing mean for Vera Therapeutics (VERA)?

This Form 3 shows that a director of Vera Therapeutics, Inc. (VERA) is now an insider for reporting purposes but currently reports no beneficial ownership of the company’s securities.

Does the reporting person own Vera Therapeutics (VERA) stock according to this Form 3?

No. The remarks section explicitly states that no securities are beneficially owned by the reporting person.

What is the relationship of the reporting person to Vera Therapeutics (VERA)?

The filing identifies the reporting person as a Director of Vera Therapeutics, Inc., with the director box checked and no other roles selected.

Are there any derivative securities reported for Vera Therapeutics (VERA) in this Form 3?

No. The derivative securities table is present in the form structure, but the remarks state that no securities are beneficially owned, which includes derivative securities.

Is this Form 3 for one individual or a group at Vera Therapeutics (VERA)?

The filing indicates that it is a Form filed by one reporting person, not by more than one reporting person.